trending Market Intelligence /marketintelligence/en/news-insights/trending/olmbkruigknt7saiprn9pa2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

STAAR Surgical closes common stock offering


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

STAAR Surgical closes common stock offering

STAAR Surgical Co. closed an underwritten public offering of 1,999,850 common shares priced at $39 apiece, raising gross proceeds of about $78 million.

The shares sold include the full exercise of the underwriter's option to buy up to an additional 260,850 common shares in the offering.

Monrovia, Calif.-based STAAR Surgical develops and manufactures implantable lenses and companion delivery systems for the eye.

Canaccord Genuity acted as the sole book-running manager for the transaction.